Number of employees
7
Annual revenue
$800000
The advances in technologies to facilitate biological and medical research have enhanced the rate of discovery of potential disease targets. The challenge for the Pharmaceutical and Biotechnology industry is first, how to effectively validate targets and second, how to develop effective therapeutic entities against these targets. Monoclonal antibodies have emerged as effective agents for both target validation and as therapeutics in their own right.